SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG.X) is trending, and the community is actively engaging in the classic "What's UpDog?" joke, driving much of the conversation. This meme coin on the Solana network, with locked liquidity and a dedicated community, is striving to be the top dog. Amidst the humor, some users are questioning the token's utility and suggesting that the trending status might be artificially driven.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW.X is trending as the community rallies around the 'crow with knife' meme, calling it the only option for generational wealth. Discussions highlight its strong community, deflationary mechanisms, and expansion across multiple chains. The focus remains on community engagement and the potential for significant growth within the meme coin sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to positive Phase 2 trial results for its hidradenitis suppurativa treatment, sonelokimab, generating significant community excitement. Discussions revolve around the drug's potential efficacy and a possible acquisition, with some speculating on buyout prices and comparing it to competitor data. The stock's high short interest and potential for a squeeze are also being actively discussed.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

Pandu Pandas ($PANDU.X) is trending, with community members highlighting its recent listing on MEXC and drawing comparisons to other successful meme coins. Bullish sentiment is fueled by perceived solid fundamentals and the project's NFT ranking, with many urging others to research the token. Some users are also discussing preferred wallets for holding $PANDU.X.

BRETT the dancer, gamer, and cultural icon of BASE chain (some like to call me the PEPE of BASE).

Brett

BRETT.X is trending as the community discusses its potential, particularly within the Base ecosystem, while comparing it to other meme coins like TOSHI.X and JTRAMBO. Bullish sentiment is fueled by technical analysis suggesting upside continuation and speculation around a possible Binance or Coinbase listing. Some traders are suggesting it might be time to accumulate $BRETT.X

A composable native asset bridge with unified liquidity and instant guaranteed finality

Stargate

Stargate is trending due to news of LayerZero's acquisition, with a community vote passing for STG holders to convert to ZRO. There's also buzz around the token's role in bridging and burning $CAW.X, with some users highlighting Hyperliquid's new direct deposit feature via Stargate.

LayerZero

LayerZero is trending due to its role in enabling cross-chain functionality, particularly with meme coin $CAW.X. The community is highlighting $CAW.X as the first Cronos project to utilize LayerZero, similar to how $USDC.X and $PEPE.X use it, expressing bullish sentiment and discussing its multichain capabilities.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors discuss its potential turnaround, drawing comparisons to AMD's earlier growth. A recent video highlighting BlackBerry's prospects is circulating, with the community focused on the company's QNX technology and anticipation for upcoming earnings. Optimism is building around partnerships and profitability.

WeRide, Inc. is a holding company, which engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers, and related sensor suites. The company was founded by Tony Xu Han and Yan Li on March 13, 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WRD is trending as investors discuss NVIDIA's Q4 2024 share purchase and a strategic equity investment from Grab, anticipating market impact and potential deployments. The community is weighing these developments against concerns about Chinese EV export regulations and comparing WRD's progress to competitors like Pony.ai, focusing on profitability timelines and key partnerships.

Doodles is a next-generation entertainment company focused on immersive storytelling through the creation and distribution of live and digital experiences, original content, and lifestyle products.  Doodles mission is to define the standard for immersive storytelling and color the world with joy.

Doodle Inu

Doodle Inu ($DOOD.X) is trending as the community rallies around a potential breakout, particularly a push towards the 50 mark.  Enthusiasm is fueled by recent price appreciation and comparisons to other meme coins, with some speculating on future collaborations and airdrops.  However, some users are expressing concerns about bot activity and potential pullbacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.77% and +47.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates

YmAbs Therapeutics (YMAB) delivered earnings and revenue surprises of +74.07% and +5.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates

scPharmaceuticals (SCPH) delivered earnings and revenue surprises of -13.33% and -2.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

Forecasting The Future: 4 Analyst Projections For Cue Biopharma

Latest Ratings for CUE
 DateFirmActionFromTo Nov 2020BerenbergInitiates Coverage OnBuy May 2020StifelMaintainsBuy May 2020OppenheimerMaintainsOutperform
 View More Analyst Ratings for CUE...

Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...

Navalign LLC Takes $66,000 Position in Cue Biopharma, Inc. (NASDAQ:CUE)

Navalign LLC bought a new stake in shares of Cue Biopharma, Inc. (NASDAQ:CUE  Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities  Exchange...

Jefferies Financial Group Begins Coverage on Cue Biopharma (NASDAQ:CUE)

Jefferies Financial Group assumed coverage on shares of Cue Biopharma (NASDAQ:CUE  Free Report) in a research report released on Wednesday, MarketBeat reports. The firm issued a buy rating and...

Cue Biopharma presenting data on lead clinical asset CUE-101 at symposium

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cue Biopharma's Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$0.7098
Prev Close	$0.6901
Open	$0.69
Dividend Yield	0.00%
50-Day Moving Average	$0.7924
Beta	1.38
Avg. Volume	124,447.19
PE Ratio	-1.29

52-Week High	$1.99
52-Week Low	$0.5406
Market Capitalization	$54.55M
EPS (Annual)	-$0.7221
Price to Book	2.99
Revenue Per Employee	$226,512.20
Enterprise Value/EBITDA	N/A

CUE
Cue Biopharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CUE News

CUE Cue Biopharma Inc